Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$290.92
+0.8%
$300.86
$253.30
$346.85
$156.41B0.592.79 million shs2.61 million shs
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
$152.60
+1.0%
$155.23
$135.34
$183.64
$349.45M0.858,317 shs7,499 shs
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
$155.97
+5.3%
$150.74
$129.14
$160.18
$7.00B0.82418,948 shs395,504 shs
RTX Co. stock logo
RTX
RTX
$126.13
+0.3%
$128.37
$99.07
$136.17
$168.50B0.585.51 million shs5.67 million shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+0.82%+4.68%-6.62%+2.43%+6.20%
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
+1.05%+3.18%-3.01%-7.54%-2.20%
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
-0.39%+3.73%+1.80%-0.88%+20.12%
RTX Co. stock logo
RTX
RTX
+0.25%+4.67%-4.85%-2.33%+24.24%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amgen Inc. stock logo
AMGN
Amgen
4.0689 of 5 stars
2.22.03.33.93.42.50.6
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/AN/AN/AN/AN/AN/AN/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/AN/AN/AN/AN/AN/AN/AN/A
RTX Co. stock logo
RTX
RTX
4.9186 of 5 stars
4.55.02.50.92.63.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.43
Hold$310.576.75% Upside
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
2.67
Moderate Buy$152.60N/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
2.77
Moderate Buy$155.97N/A
RTX Co. stock logo
RTX
RTX
3.00
Buy$161.0627.70% Upside

Current Analyst Ratings Breakdown

Latest BBH, AMGN, ITA, and RTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/28/2025
RTX Co. stock logo
RTX
RTX
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$150.00 ➝ $145.00
4/25/2025
RTX Co. stock logo
RTX
RTX
DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Hold$129.00
4/23/2025
RTX Co. stock logo
RTX
RTX
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$150.00 ➝ $140.00
4/23/2025
RTX Co. stock logo
RTX
RTX
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$147.00 ➝ $140.00
4/23/2025
RTX Co. stock logo
RTX
RTX
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $138.00
4/23/2025
RTX Co. stock logo
RTX
RTX
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$135.00
4/22/2025
Amgen Inc. stock logo
AMGN
Amgen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight ➝ Neutral$305.00
4/15/2025
RTX Co. stock logo
RTX
RTX
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$136.00 ➝ $144.00
4/14/2025
Amgen Inc. stock logo
AMGN
Amgen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$315.00 ➝ $319.00
4/10/2025
RTX Co. stock logo
RTX
RTX
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$153.00 ➝ $148.00
4/9/2025
Amgen Inc. stock logo
AMGN
Amgen
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$328.00 ➝ $330.00
(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$33.42B4.68$29.15 per share9.98$10.93 per share26.62
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/AN/AN/AN/AN/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/AN/AN/AN/AN/AN/A
RTX Co. stock logo
RTX
RTX
$81.74B2.06$9.13 per share13.81$46.48 per share2.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$4.09B$7.5538.5313.602.6312.24%176.32%11.71%5/1/2025 (Estimated)
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/A31.41N/AN/AN/AN/AN/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/AN/A30.05N/AN/AN/AN/AN/A
RTX Co. stock logo
RTX
RTX
$4.77B$3.4135.5318.442.115.91%12.45%4.75%N/A

Latest BBH, AMGN, ITA, and RTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Amgen Inc. stock logo
AMGN
Amgen
$4.18N/AN/AN/A$8.05 billionN/A
4/22/2025Q1 2025
RTX Co. stock logo
RTX
RTX
$1.35$1.47+$0.12$1.14$19.80 billion$20.31 billion
2/4/2025Q4 2024
Amgen Inc. stock logo
AMGN
Amgen
$5.04$5.31+$0.27$1.16$8.87 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$9.523.27%+8.53%126.09%14 Years
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
$1.250.82%N/AN/AN/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
$1.220.78%N/AN/AN/A
RTX Co. stock logo
RTX
RTX
$2.522.00%+7.34%73.90%N/A

Latest BBH, AMGN, ITA, and RTX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2025
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.383.05%5/16/20255/16/20256/6/2025
2/3/2025
RTX Co. stock logo
RTX
RTX
quarterly$0.631.9%2/21/20252/21/20253/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
9.62
1.26
0.95
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/AN/AN/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/AN/AN/A
RTX Co. stock logo
RTX
RTX
0.63
0.99
0.74

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
32.05%
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/A
RTX Co. stock logo
RTX
RTX
86.50%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.69%
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/A
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/A
RTX Co. stock logo
RTX
RTX
0.15%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
25,200537.65 million533.50 millionOptionable
VanEck Biotech ETF stock logo
BBH
VanEck Biotech ETF
N/A2.29 millionN/AOptionable
iShares U.S. Aerospace & Defense ETF stock logo
ITA
iShares U.S. Aerospace & Defense ETF
N/A40.80 millionN/ANot Optionable
RTX Co. stock logo
RTX
RTX
182,0001.34 billion1.33 billionOptionable

Recent News About These Companies

Asus ROG Astral RTX 5090 Senses When It Sags
RTX 5060 Ti vs RTX 4060 Ti - Test in 10 Games
RTX 4060 vs RTX 4070 - Test in 10 Games
RTX Co. stock logo
Airline Stocks To Watch Now - April 27th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amgen stock logo

Amgen NASDAQ:AMGN

$290.92 +2.36 (+0.82%)
As of 04/30/2025 04:00 PM Eastern

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

VanEck Biotech ETF stock logo

VanEck Biotech ETF NASDAQ:BBH

$152.60 +1.58 (+1.05%)
As of 04/30/2025 03:59 PM Eastern

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

iShares U.S. Aerospace & Defense ETF stock logo

iShares U.S. Aerospace & Defense ETF BATS:ITA

$155.84 +7.77 (+5.24%)
As of 04/30/2025 11:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

iShares U.S. Aerospace & Defense ETF, formerly iShares Dow Jones U.S. Aerospace & Defense Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Aerospace & Defense Index (the Index). The Index measures the performance of the aerospace and defense sector of the United States equity market. Aerospace companies include manufacturers, assemblers and distributors of aircraft and aircraft parts. Defense companies include producers of components and equipment for the defense industry, such as military aircraft, radar equipment and weapons. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Its investment advisor is BlackRock Fund Advisors.

RTX stock logo

RTX NYSE:RTX

$126.13 +0.40 (+0.32%)
As of 04/30/2025 03:59 PM Eastern

RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally. It operates through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace Systems segment offers aerospace and defense products, and aftermarket service solutions for civil and military aircraft manufacturers and commercial airlines, as well as regional, business, and general aviation, defense, and commercial space operations. This segment also designs, produces, and supports cabin interior, including oxygen systems, food and beverage preparation, storage and galley systems, and lavatory and wastewater management systems; battlespace, test and training range systems, crew escape systems, and simulation and training solutions; information management services; and aftermarket services that include spare parts, overhaul and repair, engineering and technical support, training and fleet management solutions, and asset and information management services. Its Pratt & Whitney segment supplies aircraft engines for commercial, military, business jet, and general aviation customers; and produces, sells, and services military and commercial auxiliary power units. The Raytheon segment provides defensive and offensive threat detection, tracking, and mitigation capabilities for U.S., foreign government, and commercial customers. The company was formerly known as Raytheon Technologies Corporation and changed its name to RTX Corporation in July 2023. RTX Corporation was incorporated in 1934 and is headquartered in Arlington, Virginia.